Literature DB >> 10633931

[Coloplasty after esophagectomy in cancer. A retrospective study of morbidity and mortality].

M Bilosi1, A Bernard, J P Favre, N Cheynel, H Viard, J M Devevey.   

Abstract

Aim of this study has been to evaluate retrospectively morbidity and mortality of 42 colon substitutions after resection for esophageal cancer. Colon substitution was the intervention of first choice in six patients. In the other patients the stomach was useless, because of previous gastric surgery (n = 14), of gastric involvement by the tumor (n = 21) or technical problem (n = 1). Patients have been separated in 2 groups: from 1969 to 1983 (group A, n = 22), and from 1983 to 1997 (group B, n = 20). Mortality and morbidity (all eventful postoperative course) have been collected for the 30 postoperative days. Total morbidity has been 57% as 77% in group A and 35% in group B (p < 0.05). Cervical and colo-colic leak have been the most common complications. Total mortality has been 14% as 22% in group A and 5% in group B (p < 0.1). In group A 3 patients died from anastomosis leak (intrathoracic or intraabdominal) and 2 from medical complications. In group B 1 patient died from unexplained sepsis. Our results show significative decrease of morbidity and mortality in group B. These results can be compared to those of gastroplasty for cancer or coloplasty for benign disease. In cancer of the esophagus, if stomach can not be used as substitutes, colon substitution is the best alternative, which can be used without increase of mortality and morbidity.

Entities:  

Mesh:

Year:  1999        PMID: 10633931

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  2 in total

1.  Making It Stick: Management of Gastroesophageal Junction Adenocarcinoma with Poorly-Cohesive Cells (PCC).

Authors:  Damien Bouriez; Caroline Gronnier; Haythem Najah; Denis Collet
Journal:  Dig Dis Sci       Date:  2022-04-16       Impact factor: 3.487

2.  Colon interposition for esophageal replacement: a single-center experience.

Authors:  Pietro Renzulli; Alexander Joeris; Oliver Strobel; Annemarie Hilt; Christoph A Maurer; Waldemar Uhl; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2004-01-09       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.